4.210SEK-10.04%Mkt Cap: 421.05M SEKP/E: —Last update: 2026-06-01
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activa…
Industry Peers
Medical Instruments & Supplies146.01BUSDP/E 50.0
86.09BDKKP/E 40.9
79.36BEURP/E 34.8
40.39BUSDP/E 25.6
30.12BUSDP/E 31.2
27.29BUSDP/E 18.1
25.22BCHFP/E 39.2
22.10BUSDP/E 41.8
Indicators:|
Key Statistics
Company
Market Cap421.05M SEK
Enterprise Value396.60M SEK
Revenue (TTM)83.23M SEK
Gross Profit47.81M SEK
Net Income (TTM)-15.25M SEK
Revenue/Share0.9650 SEK
Last Price4.210 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees31
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.67
PEG—
EV/EBITDA-70.80
EV/Revenue4.77
P/S5.62
P/B7.96
EPS (TTM)-0.03
EPS (Forward)0.61
52W Range
1.45081% of range4.840
52W High4.840 SEK
52W Low1.450 SEK
Profitability
Gross Margin76.48%
Oper. Margin14.06%
EBITDA Margin-6.73%
Profit Margin-24.39%
ROE-30.99%
ROA-21.55%
Growth
Revenue Growth228.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.81M SEK
CapEx (TTM)404.00K SEK
FCF Margin-13.01%
FCF Yield-2.57%
Net Debt-41.26M SEK
Net Debt/EBITDA7.36
Balance Sheet
Debt/Equity—
Current Ratio4.43
Quick Ratio3.27
Book Value/Sh0.5880 SEK
Cash/Share0.4410 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.100.01M
Float41.95M
Insiders34.25%
Institutions10.68%
Technical
SMA 503.474 (+21.2%)
SMA 2002.887 (+45.8%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)87.20K
Avg Vol (10d)99.47K
Technical Indicators
RSI (14)76.7
MACD0.3052
MACD Signal0.1966
MACD Hist.+0.1086
BB Upper4.674 SEK
BB Middle3.643 SEK
BB Lower2.613 SEK
BB Width56.55%
ATR (14)0.3063 SEK
Vol Ratio (20d)0.85x